I hesitate to make predictions about healthcare in 2022, given the turbulence we have faced in the past 2 years. Yet, medical groups, health systems, and their physicians and staff must continue to develop forward-looking plans so they can provide high-quality, accessible healthcare to their patients and communities.
Trending
- SAGA Diagnostics® Launches Ultrasensitive Pathlight™ MRD Test in Colorectal Cancer (Business Wire)
- Task force updates ERCP quality metrics (GI & Hepatology News)
- New simulator mimics real tissue for safer endoscopic cancer surgery training (Medical Xpress)
- 5 GI leaders on what’s changing in colonoscopy (Becker’s GI & Endoscopy)
- Scientists create a luminous pill with biosensors meant to replace colonoscopies (Earth.com)
- FUJIFILM 800 Series Duodenoscopes Now Compatible with CE Mark Approved ULTRA GI Cycle (Fujifilm)
- Private Equity’s Healthcare Boom Is Getting More Crowded (MedCity News)
- Nvidia, Eli Lilly to spend $1 billion over five years on joint research lab (Reuters)
